Immix Biopharma Shares Slip 3.2% On 1.7M Share Offering
marketwatch.com
news
2022-05-27 21:35:00

By Denny Jacob Immix Biopharma shares fell 3.2% to $2.60 in after-hours trading Friday after it said that it is offering about 1.7 million shares of its common stock in a secondary offering. The biopharmaceutical company said it expects about $4.3 million in net proceeds based on an offering price of $2.97, Thursday's closing price. It intends to use the net proceeds to fund patients enrolled in its planned IMX-110 Phase 2A for soft tissue sarcoma, among other trials, as well as for working capital and corporate purposes.
